Search Results

  • App Note: Rapid SARS-CoV-2 Viral Isolation from Wastewater

    APPLICATION NOTE SKU 44XXX Download full application note here Key Advantages > Nanotrap® Magnetic Virus Particles concentrate SARS-CoV-2 wastewater sample with no centrifugation or filtration.

  • App Note: Rapid SARS-CoV-2 RNA Extraction from Universal Transport Medium Pooled Sample Mimics

    APPLICATION NOTE SKU 44XXX Download full application note here Key Advantages > Nanotrap® Magnetic Virus Particles enable RNA extraction of viral RNA from 4 mL UTM sample volumes in less than 20 minutes, representing a sample extraction method that is roughly 2X faster than column-based methods. > Up to a 4-fold Ct value improvement for large volume pools across a range of viral titers, enabling detection of low viral load samples against a background of 7 negative samples in pooled sample mimics.

  • App Note: Capture and Concentration of SARS-CoV-2 from Viral Transport Medium

    APPLICATION NOTE SKU 44XXX Download full application note here Key Advantages > Nanotrap® Magnetic Virus Particles rapidly capture heat-inactivated SARS-CoV-2 from 1 mL of viral transport medium prior to RNA extraction. > Nanotrap® Magnetic Virus Particles improve detection of SARS-CoV-2 using the IDT 2019-nCoV CDC qPCR Probe Assay across 4 logs of viral titers.

  • App Note: Capture and Concentration of Coronavirus OC43

    Nanotrap® Virus Particles capture and concentrate coronavirus OC43 for improved RT-PCR detection APPLICATION NOTE SKU 44XXX Download full application note here Key Advantages > Nanotrap® processing is simple and efficient, creating quality input sample material for downstream detection. > Bring low-abundance samples into the assay dynamic range and eliminate false negatives.

  • App Note: Capture & Concentration of Influenza A from Viral Transport Media with Nanotrap® Particles

    Improving RNA extraction for a more sensitive qRT-PCR assay APPLICATION NOTE SKU 44XXX Download full application note here Key Advantages > Circumvent the low input sample volume restrictions of most extraction methods by capturing influenza A from larger volumes. > Capture and concentrate influenza virus from transport media with Nanotrap particles for greater viral RNA extraction yield and improved qRT-PCR assay sensitivity.

  • App Note: Zika Detection in Urine with Nanotrap® Virus Particles

    Improving RT-PCR detection from frozen, unpreserved first-void clinical samples APPLICATION NOTE SKU 44XXX Download full application note here Key Advantages > Capture and concentrate Zika virus from urine to boost assay sensitivity and eliminate the need for invasive blood collection. > Overcome the sensitivity challenges in frozen storage conditions by minimizing the impact of sample degradation through virus enrichment. > Circumvent the low input sample volume restrictions of commercial extraction methods by capturing more virions from larger volumes upstream. > Easily integrate into existing workflows using sample collection devices, commercial RNA extraction methods and RT-PCR assays.

  • LinkedIn Classic
  • Twitter App Icon
  • Facebook Social Icon

9460 Innovation Drive, Manassas, VA, 20110, United States

800-615-0418 / info@ceresnano.com

© 2020 Ceres Nanosciences, Inc. All Rights Reserved